Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra

Jelle Praet, Jasmien Orije, Firat Kara, Caroline Guglielmetti, Eva Santermans, Jasmijn Daans, Niel Hens, Marleen Verhoye, Zwi Berneman, Peter Ponsaerts, Annemie Van der Linden

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Conventional MRI is frequently used during the diagnosis of multiple sclerosis but provides only little additional pathological information. Proton MRS (1H-MRS), however, provides biochemical information on the lesion pathology by visualization of a spectrum of metabolites. In this study we aimed to better understand the changes in metabolite concentrations following demyelination of the white matter. Therefore, we used the cuprizone model, a well-established mouse model to mimic type III human multiple sclerosis demyelinating lesions. First, we identified CX3CL1/CX3CR1 signaling as a major regulator of microglial activity in the cuprizone mouse model. Compared with control groups (heterozygous CX3CR1+/- C57BL/6 mice and wild type CX3CR1+/+ C57BL/6 mice), microgliosis, astrogliosis, oligodendrocyte cell death and demyelination were shown to be highly reduced or absent in CX3CR1-/- C57BL/6 mice. Second, we show that 1H-MRS metabolite spectra are different when comparing cuprizone-treated CX3CR1-/- mice showing mild demyelination with cuprizone-treated CX3CR1+/+ mice showing severe demyelination and demyelination-associated inflammation. Following cuprizone treatment, CX3CR1+/+ mice show a decrease in the Glu, tCho and tNAA concentrations as well as an increased Tau concentration. In contrast, following cuprizone treatment CX3CR1-/- mice only showed a decrease in tCho and tNAA concentrations. Therefore, 1H-MRS might possibly allow us to discriminate demyelination from demyelination-associated inflammation via changes in Tau and Glu concentration. In addition, the observed decrease in tCho concentration in cuprizone-induced demyelinating lesions should be further explored as a possible diagnostic tool for the early identification of human MS type III lesions.

Original languageEnglish
Pages (from-to)505-513
Number of pages9
JournalNMR in biomedicine
Volume28
Issue number4
DOIs
StatePublished - Apr 1 2015

Keywords

  • CXCR1
  • Cuprizone
  • Demyelination
  • MRI
  • Spectroscopy

Fingerprint

Dive into the research topics of 'Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra'. Together they form a unique fingerprint.

Cite this